18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis.
18F-fluoromisonidazole (FMISO) is a positron emission tomography (PET) tracer that accumulates in hypoxic tissues. We here present a case of suspected cardiac sarcoidosis which was detected with increased FMISO uptake.
['Manabe|Osamu|O|', 'Hirata|Kenji|K|', 'Shozo|Okamoto|O|', 'Shiga|Tohru|T|', 'Uchiyama|Yuko|Y|', 'Kobayashi|Kentaro|K|', 'Watanabe|Shiro|S|', 'Toyonaga|Takuya|T|', 'Kikuchi|Hisaya|H|', 'Oyama-Manabe|Noriko|N|', 'Tamaki|Nagara|N|']
D000368:Aged D009202:Cardiomyopathies D003937:Diagnosis, Differential D005260:Female D006801:Humans D008920:Misonidazole D049268:Positron-Emission Tomography D019275:Radiopharmaceuticals D012507:Sarcoidosis D051598:Whole Body Imaging
FMISO cardiac sarcoidosis FDG inflammation